Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2012 16:06 ET | Source: Biota

Biota Announces Shareholder Approval of Merger With Nabi Pharmaceuticals

MELBOURNE, AUSTRALIA--(Marketwire - Oct 23, 2012) - Biota Holdings Limited (ASX: BTA) today announced shareholder approval of a merger with Nabi Biopharmaceuticals to create the combined company,...
October 23, 2012 05:15 ET | Source: Biota

Biota Announces Approval of Definitive Merger Agreement by Nabi Shareholders

MELBOURNE, AUSTRALIA--(Marketwire - Oct 23, 2012) - Biota Holdings Limited (ASX: BTA) (Biota) announces that the shareholders of Nabi Biopharmaceuticals Inc. (Nabi) have approved proposals related...
October 23, 2012 05:15 ET | Source: Sunshine Heart

Sunshine Heart Receives 2012 Frost & Sullivan North American Heart Failure Treatment New Product Innovation Award for C-Pulse(R)

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Oct 23, 2012) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC), a global medical device company focused on innovative technologies for...
October 18, 2012 14:11 ET | Source: Sunshine Heart

Sunshine Heart's Feasibility Study Data to Be Presented at 2012 Transcatheter Cardiovascular Therapeutics Conference

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Oct 18, 2012) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC), a global medical device company focused on innovative technologies for...
October 15, 2012 05:15 ET | Source: Genetic Technologies

Genetic Technologies Files Patent Infringement Suits Against Multiple Alleged Infringers in USA

MELBOURNE, AUSTRALIA--(Marketwire - Oct 15, 2012) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) advises that, in conjunction with its assertion partner Sheridan Ross P.C., the Company...
October 11, 2012 05:30 ET | Source: Benitec Biopharma

Benitec Announces Acquisition of Tacere Therapeutics and Phase I/II Ready Hepatitis C (HCV) Program

SYDNEY, AUSTRALIA and SAN JOSE, CA--(Marketwire - Oct 11, 2012) - Benitec Biopharma (ASX: BLT) Key points: Acquisition of US-based Tacere Therapeutics brings...
October 01, 2012 05:30 ET | Source: Audeo Oncology, Inc.

Audeo Oncology Announces New Board Appointments

SAN FRANCISCO, CA and BRISBANE, AUSTRALIA--(Marketwire - Oct 1, 2012) - Audeo Oncology, Inc. (Audeo) announces today the appointment of Leigh Bonney, Susan Kelley and David U'Prichard to its Board...
October 01, 2012 05:15 ET | Source: Sunshine Heart

Sunshine Heart Announces Conditional Approval of IDE From the FDA for C-Pulse(R) Heart Assist System

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Oct 1, 2012) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC), a global medical device company focused on innovative technologies for moderate...
September 27, 2012 05:15 ET | Source: Vital Therapies

Vital Therapies, Inc. Announces First Closing of $76 Million Staged Financing to Fund Phase 3 Pivotal Clinical Trials of ELAD(R) in USA and EU

SAN DIEGO, CA--(Marketwire - Sep 27, 2012) - Vital Therapies, Inc., a development stage biotechnology company focused on human allogeneic cellular therapy for life-threatening acute liver failure,...
September 25, 2012 05:15 ET | Source: Genetic Technologies

Genetic Technologies Announces BREVAGen(TM) Attains Clearance for Sale Into Florida

MELBOURNE, AUSTRALIA--(Marketwire - Sep 25, 2012) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that BREVAGen™ has been cleared for sale into the State of...